Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Science

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2008.01079.xPMID 19175607PMCID PMC11158143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase

  2014cited by this paper
• A High Affinity Hepatocyte Growth Factor-binding Site in the Immunoglobulin-like Region of Met

  2008cited by this paper
• From Tpr-Met to Met, tumorigenesis and tubes

  2007cited by this paper
• VEGF Induces Tie2 Shedding via a Phosphoinositide 3-Kinase/Akt–Dependent Pathway to Modulate Tie2 Signaling

  2007cited by this paper
• Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter

  2007cited by this paper
• Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density.

  2006cited by this paper
• Invasive growth: a MET-driven genetic programme for cancer and stem cells

  2006cited by this paper
• Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells: Proliferation, Migration, and Differentiation

  2006cited by this paper
• Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity.

  2006cited by this paper
• c-Met Ectodomain Shedding Rate Correlates with Malignant Potential

  2006cited by this paper
• An alternatively spliced form of Met receptor is tumorigenic

  2006cited by this paper
• Truncated RON Tyrosine Kinase Drives Tumor Cell Progression and Abrogates Cell-Cell Adhesion Through E-Cadherin Transcriptional Repression

  2004cited by this paper
• Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele.

  2004cited by this paper
• Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.

  2003cited by this paper
• Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor

  2003cited by this paper
• c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.

  2003cited by this paper
• Met, metastasis, motility and more

  2003cited by this paper
• Series Introduction: Invasive growth: from development to metastasis

  2002cited by this paper
• The endophilin–CIN85–Cbl complex mediates ligand-dependent downregulation of c-Met

  2002cited by this paper
• Dysregulation of Met receptor tyrosine kinase activity in invasive tumors.

  2002cited by this paper
• Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-β signalling in the control of liver homeostasis and transformation

  2002cited by this paper
• Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

  2000cited by this paper
• Enhanced Transformation by a Plasma Membrane-Associated Met Oncoprotein: Activation of a Phosphoinositide 3′-Kinase-Dependent Autocrine Loop Involving Hyaluronic Acid and CD44

  2000cited by this paper
• Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.

  2000cited by this paper
• Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists

  1999cited by this paper
• Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET

  1999cited by this paper
• Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF.

  1998cited by this paper
• Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor

  1998cited by this paper
• Activating mutations for the met tyrosine kinase receptor in human cancer.

  1997cited by this paper
• Constitutive Proteolysis of the ErbB-4 Receptor Tyrosine Kinase by a Unique, Sequential Mechanism

  1997cited by this paper
• Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

  1997cited by this paper
• A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.

  1996cited by this paper
• EXPRESSION OF Met PROTEIN IN THYROID TUMOURS

  1996cited by this paper
• TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment

  1996cited by this paper
• Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells.

  1995cited by this paper
• The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.

  1995cited by this paper
• Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum.

  1994cited by this paper
• Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.

  1994cited by this paper
• Soluble receptors for cytokines and growth factors: generation and biological function.

  1994cited by this paper
• Structural and functional domains critical for constitutive activation of the HGF-receptor (Met).

  1994cited by this paper
• Copyright � 1995, American Society for Microbiology Isolation of New Oncogenic Forms of the Murine c-fms Gene

  1994cited by this paper
• Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene.

  1993cited by this paper
• c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.

  1991cited by this paper
• C-terminal truncated forms of Met, the hepatocyte growth factor receptor

  1991cited by this paper
• Serum transferrin receptor is a truncated form of tissue receptor.

  1990cited by this paper
• Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms

  1989cited by this paper
• Activation of transforming potential of the human insulin receptor gene.

  1987cited by this paper
• Mechanism of met oncogene activation.

  1986cited by this paper
• 42,000-molecular weight EGF receptor has protein kinase activity

  1984cited by this paper
• Insulin-like effect of trypsin on the phosphorylation of rat adipocyte insulin receptor.

  1983cited by this paper

• Deletion of the plexin-D1 ectodomain leads to anoikis by suppressing integrin inside-out signaling.

  2025cites this paper
• EpCAM Signaling in Oral Cancer Stem Cells: Implications for Metastasis, Tumorigenicity, and Therapeutic Strategies

  2025cites this paper
• The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies

  2022cites this paper
• Conserved Roles for Receptor Tyrosine Kinase Extracellular Regions in Regulating Receptor and Pathway Activity

  2020cites this paper
• A novel immunohistochemical scoring system reveals associations of C-terminal MET, ectodomain shedding and loss of E-cadherin with poor prognosis in oral squamous cell carcinoma.

  2020cites this paper
• The Mechanisms of Proliferation and Energy Metabolism in Oral Cancer

  2019cites this paper
• MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinoma

  2019cites this paper
• Avaliação da sinalização de c-met e seus efeitos em linhagens celulares de carcinoma mucoepidermóide

  2018cites this paper
• Met Activation and Carcinogenesis

  2018cites this paper
• Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.

  2017cites this paper
• c-Met expression and activity in urogenital cancers – novel aspects of signal transduction and medical implications

  2017cites this paper
• MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering

  2017cites this paper
• Overexpression of miR-31-5p inhibits human chordoma cells proliferation and invasion by targeting the oncogene c-Met through suppression of AKT/PI3K signaling pathway.

  2017cites this paper
• Alteration status and prognostic value of MET in head and neck squamous cell carcinoma

  2016cites this paper
• Plasticity of Cancer Cell Invasion-Mechanisms and Implications for Therapy.

  2016cites this paper
• Molecular Signaling in Oral Cancer Invasion and Metastasis

  2016cites this paper
• Short-form Ron is a novel determinant of ovarian cancer initiation and progression

  2016cites this paper
• Live cell imaging shows hepatocyte growth factor-induced Met dimerization.

  2016cites this paper
• c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences

  2015cites this paper
• Identification of biomarkers for development of NF1-associated malignant peripheral nerve sheath tumours

  2015cites this paper
• Physiological Signaling and Structure of the HGF Receptor MET

  2014cites this paper
• Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells

  2013cites this paper
• The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation

  2013cites this paper
• Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.

  2013cites this paper
• The Crosstalk of c-MET with Related Receptor Tyrosine Kinases in Urothelial Bladder Cancer

  2013cites this paper
• Isolation and Characterization of a Spontaneously Immortalized Multipotent Mesenchymal Cell Line Derived from Mouse Subcutaneous Adipose Tissue

  2013cites this paper
• Insights into Nod factor signaling mediated by Medicago truncatula LysM receptor-like kinases, MtNFP and MtLYK3

  2012cites this paper
• UvA-DARE (Digital Academic Repository) Insights into Nod factor signaling mediated by Medicago truncatula LysM receptor-like kinases, MtNFP and MtLYK3 Pietraszewska, A. Link to publication Citation for published version (APA): Pietraszewska-Bogiel, A. (2012). Insights into Nod factor signaling media

  2012cites this paper
• Hepatocyte growth factor, c-Met and syndecan-1 in multiple myeloma

  2011cites this paper
• Soluble c‐Met in serum of patients with multiple myeloma: correlation with clinical parameters

  2011cites this paper
• Structural insights into Met receptor activation.

  2011cites this paper
• Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET

  2011cites this paper
• Head neck squamous cell carcinoma c‐Met+ cells display cancer stem cell properties and are responsible for cisplatin‐resistance and metastasis

  2011cites this paper
• Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production.

  2010cites this paper
• Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase

  2010cites this paper
• Crosstalk in Met receptor oncogenesis.

  2009cites this paper
• The function, proteolytic processing, and histopathology of Met in cancer.

  2009cites this paper
• Running title : A spontaneously immortalized mesenchymal cell line Isolation and characterization of a spontaneously immortalized multipotent mesenchymal cell line derived from mouse subcutaneous adipose tissue

  year unknowncites this paper